Finance

Lists
Why is SIGHT up 3.90%?
Dive Deeper
SIGHT:EPA
Gensight Biologics SA
€0.077
+3.90%
(+0.0029) 1D
Oct 30, 5:35:10 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SIGHT...
Open
€0.08
High
€0.08
Low
€0.07
Mkt. cap
17.59M
Avg. vol.
1.55M
Volume
593.66K
52-wk high
€0.24
52-wk low
€0.07
EPS
-€0.08
Shares outstanding
246.22M
No. of employees
18
Open
€0.08
High
€0.08
Low
€0.07
Mkt. cap
17.59M
Avg. vol.
1.55M
Volume
593.66K
52-wk high
€0.24
52-wk low
€0.07
EPS
-€0.08
Shares outstanding
246.22M
No. of employees
18
News stories
From web sources and news partners
About Gensight Biologics SA
CEO-
Employees18
Founded2012
HeadquartersParis, ÃŽle-de-France, France
SectorBiotechnology
Last report
Jul 8, 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (EUR)
-428.00K / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
-839.24%
-839.24%
1,199.88%
1,199.88%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps